Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
539
-
Total 13F shares, excl. options
-
177,134,050
-
Shares change
-
+1,192,325
-
Total reported value, excl. options
-
$15,645,638,303
-
Value change
-
+$125,285,951
-
Put/Call ratio
-
71.1%
-
Number of buys
-
253
-
Number of sells
-
-215
-
Price
-
$88.35
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2021
626 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2021.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 539 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177,134,050 shares
of 193,539,047 outstanding shares and own 91.52% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (17,804,780 shares), VANGUARD GROUP INC (16,351,031 shares), Dodge & Cox (14,825,049 shares), BlackRock Inc. (13,901,181 shares), Capital Research Global Investors (12,672,008 shares), BAKER BROS. ADVISORS LP (7,620,494 shares), AMERIPRISE FINANCIAL INC (6,551,661 shares), STATE STREET CORP (5,316,093 shares), Clearbridge Investments, LLC (5,263,592 shares), and JANUS HENDERSON GROUP PLC (3,894,237 shares).
This table shows the top 539 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.